Literature DB >> 10568139

Measurements of bone mineral density. Mineral density in metabolic bone disease.

M Fischer1, F Raue.   

Abstract

Bone metabolism and thus bone remodelling and bone mineral content are profoundly influenced by many hormonal and metabolic factors. This review presents the state of the art procedures for bone mineral absorptiometry and examines the interactions of endocrine and metabolic diseases and bone mineral content. Preventive and therapeutic modalities of osteoporosis are discussed in this context.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10568139

Source DB:  PubMed          Journal:  Q J Nucl Med        ISSN： 1125-0135


  3 in total

1.  Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women.

Authors:  L G Rao; E S Mackinnon; R G Josse; T M Murray; A Strauss; A V Rao
Journal:  Osteoporos Int       Date:  2006-08-29       Impact factor: 4.507

2.  Estrogen deficiency and low-calcium diet increased bone loss and urinary calcium excretion but did not alter arterial stiffness in young female rats.

Authors:  Jong-Hoon Park; Naomi Omi; Toshiya Nosaka; Ayako Kitajima; Ikuko Ezawa
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

3.  The effects of different exercise modes for preventing endothelial dysfunction of arteries and bone loss in ovariectomized rats.

Authors:  Jonghoon Park; Naomi Omi
Journal:  J Exerc Nutrition Biochem       Date:  2014-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.